‘Text/HTML’ of page ‘NRG-GI008: CIRCULATE-US Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease ‘
Clinical Studies FAQ
Read MoreContent Block Tag: NRG-GI008: CIRCULATE-US Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
‘Text/HTML’ of page ‘NRG-GI008: CIRCULATE-US Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease ‘
CIRCULATE-US STUDY FAQ
Read More‘Text/HTML’ of page ‘NRG-GI008: CIRCULATE-US Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease ‘
Frequently Asked Questions Below, you can find FAQs about clinical research and this particular clinical trial.
Read More‘Text/HTML’ of page ‘NRG-GI008: CIRCULATE-US Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease ‘
About This Study NRG-GI008, also known as the “CIRCULATE-NORTH AMERICA” trial, is a clinical study for people with stage III and high-risk stage II colon cancer. The study will be seeking to determine whether chemotherapy is needed for all or only some patients in this population, and, if chemotherapy is needed, what kind of chemotherapy […]
Read More‘Text/HTML’ of page ‘NRG-GI008: CIRCULATE-US Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease ‘
THE CIRCULATE-NORTH AMERICA STUDY FAQ
Read More‘Text/HTML’ of page ‘NRG-GI008: CIRCULATE-US Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease ‘
CIRCULATE-US FAQ
Read More